Cargando…
Development and Validation of a Clinical Trial Patient Stratification Assay That Interrogates 27 Mutation Sites in MAPK Pathway Genes
Somatic mutations identified on genes related to the cancer-developing signaling pathways have drawn attention in the field of personalized medicine in recent years. Treatments developed to target a specific signaling pathway may not be effective when tumor activating mutations occur downstream of t...
Autores principales: | Chang, Ken C. N., Galuska, Stefan, Weiner, Russell, Marton, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749116/ https://www.ncbi.nlm.nih.gov/pubmed/23991070 http://dx.doi.org/10.1371/journal.pone.0072239 |
Ejemplares similares
-
Interrogating PP1 Activity in the MAPK Pathway with Optimized PP1‐Disrupting Peptides
por: Wang, Yansong, et al.
Publicado: (2018) -
Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics
por: Pant, Saumya, et al.
Publicado: (2014) -
A molecular toolbox for interrogation of membrane contact sites
por: Jing, Ji, et al.
Publicado: (2019) -
Transwell migration assay to interrogate human CAR-T cell chemotaxis
por: Oner, Arman, et al.
Publicado: (2022) -
HTS-Compatible β-Lactamase Transcriptional Reporter Gene Assay for Interrogating the Heat Shock Response Pathway
por: Hancock, Michael K, et al.
Publicado: (2009)